JMV3002 is primarily used in research settings to study its effects on the central nervous system, particularly in relation to anxiety and stress-related disorders. It acts as a selective antagonist for the delta-opioid receptor, making it a valuable tool for understanding the role of these receptors in modulating emotional and behavioral responses. Additionally, JMV3002 has shown potential in preclinical studies for its ability to reduce anxiety-like behaviors without the side effects commonly associated with traditional anxiolytics. Its application extends to exploring novel therapeutic strategies for mental health conditions, offering insights into the development of targeted treatments for anxiety and depression.